• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向流感血凝素保守茎区的中和抗体。

Neutralizing Antibodies Targeting the Conserved Stem Region of Influenza Hemagglutinin.

作者信息

Nath Neerukonda Sabari, Vassell Russell, Weiss Carol D

机构信息

Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA.

出版信息

Vaccines (Basel). 2020 Jul 12;8(3):382. doi: 10.3390/vaccines8030382.

DOI:10.3390/vaccines8030382
PMID:32664628
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7563823/
Abstract

Influenza continues to be a public health threat despite the availability of annual vaccines. While vaccines are generally effective at inducing strain-specific immunity, they are sub-optimal or ineffective when drifted or novel pandemic strains arise due to sequence changes in the major surface glycoprotein hemagglutinin (HA). The discovery of a large number of antibodies targeting the highly conserved stem region of HAs that are capable of potently neutralizing a broad range of virus strains and subtypes suggests new ways to protect against influenza. The structural characterization of HA stem epitopes and broadly neutralizing antibody paratopes has enabled the design of novel proteins, mini-proteins, and peptides targeting the HA stem, thus providing a foundation for the design of new vaccines. In this narrative, we comprehensively review the current knowledge about stem-directed broadly neutralizing antibodies and the structural features contributing to virus neutralization.

摘要

尽管每年都有流感疫苗可用,但流感仍然是一种公共卫生威胁。虽然疫苗通常能有效诱导针对特定毒株的免疫力,但当主要表面糖蛋白血凝素(HA)因序列变化出现抗原漂移或新型大流行毒株时,疫苗的效果就会欠佳或无效。大量靶向HA高度保守茎区的抗体能够有效中和多种病毒毒株和亚型,这一发现为预防流感提供了新途径。HA茎区表位和广泛中和性抗体互补位的结构特征,使得针对HA茎区的新型蛋白质、微型蛋白质和肽得以设计,从而为新型疫苗的设计奠定了基础。在本综述中,我们全面回顾了目前关于靶向茎区的广泛中和性抗体以及有助于病毒中和的结构特征的知识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dca/7563823/c1350ab3d898/vaccines-08-00382-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dca/7563823/b823c0c3f703/vaccines-08-00382-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dca/7563823/c1350ab3d898/vaccines-08-00382-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dca/7563823/b823c0c3f703/vaccines-08-00382-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dca/7563823/c1350ab3d898/vaccines-08-00382-g002.jpg

相似文献

1
Neutralizing Antibodies Targeting the Conserved Stem Region of Influenza Hemagglutinin.靶向流感血凝素保守茎区的中和抗体。
Vaccines (Basel). 2020 Jul 12;8(3):382. doi: 10.3390/vaccines8030382.
2
Conformational Stability of the Hemagglutinin of H5N1 Influenza A Viruses Influences Susceptibility to Broadly Neutralizing Stem Antibodies.H5N1 流感病毒血凝素的构象稳定性影响对广谱中和茎部抗体的敏感性。
J Virol. 2018 May 29;92(12). doi: 10.1128/JVI.00247-18. Print 2018 Jun 15.
3
Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.新型 H3 特异性广谱中和单克隆抗体的鉴定 该抗体靶向血凝素球状头部,来源于一位具有广泛血清学反应性的流感病毒免疫供者
J Virol. 2020 Feb 28;94(6). doi: 10.1128/JVI.01035-19.
4
Mutations in Influenza A Virus Neuraminidase and Hemagglutinin Confer Resistance against a Broadly Neutralizing Hemagglutinin Stem Antibody.甲型流感病毒神经氨酸酶和血凝素的突变赋予了对广泛中和血凝素茎抗体的抗性。
J Virol. 2019 Jan 4;93(2). doi: 10.1128/JVI.01639-18. Print 2019 Jan 15.
5
Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design.通过去除流感病毒血凝素蛋白的N-连接糖基化位点来揭示茎特异性中和表位用于疫苗设计
J Virol. 2016 Sep 12;90(19):8496-508. doi: 10.1128/JVI.00880-16. Print 2016 Oct 1.
6
Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans.人类接种H5N1疫苗后对流感血凝素茎区产生广泛交叉反应性抗体应答
Proc Natl Acad Sci U S A. 2014 Sep 9;111(36):13133-8. doi: 10.1073/pnas.1414070111. Epub 2014 Aug 25.
7
Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones.广泛中和抗流感病毒抗体:多克隆混合物及IgA骨架中中和效力的增强
J Virol. 2015 Apr;89(7):3610-8. doi: 10.1128/JVI.03099-14. Epub 2015 Jan 14.
8
Identification and structural characterization of a broadly neutralizing antibody targeting a novel conserved epitope on the influenza virus H5N1 hemagglutinin.鉴定和结构表征针对流感病毒 H5N1 血凝素上新型保守表位的广谱中和抗体。
J Virol. 2013 Feb;87(4):2215-25. doi: 10.1128/JVI.02344-12. Epub 2012 Dec 5.
9
Characterization of humoral and cell-mediated immunity induced by mRNA vaccines expressing influenza hemagglutinin stem and nucleoprotein in mice and nonhuman primates.在小鼠和非人灵长类动物中,表达流感血凝素茎和核蛋白的 mRNA 疫苗诱导的体液和细胞免疫特性。
Vaccine. 2022 Jul 30;40(32):4412-4423. doi: 10.1016/j.vaccine.2022.03.063. Epub 2022 Jun 6.
10
Characterization of a broadly neutralizing monoclonal antibody that targets the fusion domain of group 2 influenza A virus hemagglutinin.一种靶向2型甲型流感病毒血凝素融合结构域的广泛中和单克隆抗体的特性分析。
J Virol. 2014 Dec;88(23):13580-92. doi: 10.1128/JVI.02289-14. Epub 2014 Sep 10.

引用本文的文献

1
Nanobodies: a new frontier in influenza virus neutralization.纳米抗体:流感病毒中和的新前沿。
Folia Microbiol (Praha). 2025 Jul 23. doi: 10.1007/s12223-025-01303-2.
2
Passive Immunization in the Prevention and Treatment of Viral Infections.被动免疫在病毒感染预防与治疗中的应用
Eur J Immunol. 2025 May;55(5):e202451606. doi: 10.1002/eji.202451606.
3
Neuraminidase-specific antibodies drive differential cross-protection between contemporary FLUBV lineages.神经氨酸酶特异性抗体在当代流感病毒B型毒株谱系之间产生不同的交叉保护作用。

本文引用的文献

1
Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients.致病性T细胞和炎性单核细胞在重症COVID-19患者中引发炎症风暴。
Natl Sci Rev. 2020 Jun;7(6):998-1002. doi: 10.1093/nsr/nwaa041. Epub 2020 Mar 13.
2
Different genetic barriers for resistance to HA stem antibodies in influenza H3 and H1 viruses.流感 H3 和 H1 病毒对 HA 茎抗体的耐药性存在不同的遗传屏障。
Science. 2020 Jun 19;368(6497):1335-1340. doi: 10.1126/science.aaz5143.
3
Generation of a protective murine monoclonal antibody against the stem of influenza hemagglutinins from group 1 viruses and identification of resistance mutations against it.
Sci Adv. 2025 Mar 28;11(13):eadu3344. doi: 10.1126/sciadv.adu3344.
4
How Broadly Neutralising Antibodies Are Redefining Immunity to Influenza.广泛中和抗体如何重新定义对流感的免疫力
Antibodies (Basel). 2025 Jan 7;14(1):4. doi: 10.3390/antib14010004.
5
Cross-protection against influenza viruses by chimeric M2e-H3 stalk protein or multi-subtype neuraminidase plus M2e virus-like particle vaccine in ferrets.嵌合 M2e-H3 茎蛋白或多亚型神经氨酸酶加 M2e 病毒样颗粒疫苗对雪貂流感病毒的交叉保护作用。
Virology. 2024 Jul;595:110097. doi: 10.1016/j.virol.2024.110097. Epub 2024 Apr 25.
6
Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge.Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge.
Nat Commun. 2024 Feb 20;15(1):1553. doi: 10.1038/s41467-024-45404-x.
7
Development of Self-Assembled Protein Nanocage Spatially Functionalized with HA Stalk as a Broadly Cross-Reactive Influenza Vaccine Platform.基于空间功能化 HA 茎的自组装蛋白纳米笼的开发作为一种广谱交叉反应性流感疫苗平台。
ACS Nano. 2023 Dec 26;17(24):25045-25060. doi: 10.1021/acsnano.3c07669. Epub 2023 Dec 12.
8
Enhancing breadth and durability of humoral immune responses in non-human primates with an adjuvanted group 1 influenza hemagglutinin stem antigen.使用佐剂化的1型流感血凝素茎抗原增强非人类灵长类动物体液免疫反应的广度和持久性。
NPJ Vaccines. 2023 Nov 11;8(1):176. doi: 10.1038/s41541-023-00772-1.
9
Epistasis reduces fitness costs of influenza A virus escape from stem-binding antibodies.上位性降低了甲型流感病毒逃避茎结合抗体的适应代价。
Proc Natl Acad Sci U S A. 2023 Apr 25;120(17):e2208718120. doi: 10.1073/pnas.2208718120. Epub 2023 Apr 17.
10
Influenza and Universal Vaccine Research in China.中国的流感和通用疫苗研究。
Viruses. 2022 Dec 30;15(1):116. doi: 10.3390/v15010116.
生成针对 1 组流感血凝素茎部的保护性鼠单克隆抗体,并鉴定对其的耐药突变。
PLoS One. 2019 Sep 12;14(9):e0222436. doi: 10.1371/journal.pone.0222436. eCollection 2019.
4
Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses.嵌合纳米颗粒展示多样化的流感病毒血凝素可引发广泛的 B 细胞反应。
Nat Immunol. 2019 Mar;20(3):362-372. doi: 10.1038/s41590-018-0305-x. Epub 2019 Feb 11.
5
Influenza Vaccines: Good, but We Can Do Better.流感疫苗:效果良好,但我们可以做得更好。
J Infect Dis. 2019 Apr 8;219(Suppl_1):S1-S4. doi: 10.1093/infdis/jiy633.
6
Neuraminidase inhibition contributes to influenza A virus neutralization by anti-hemagglutinin stem antibodies.神经氨酸酶抑制作用有助于抗血凝素茎部抗体对甲型流感病毒的中和作用。
J Exp Med. 2019 Feb 4;216(2):304-316. doi: 10.1084/jem.20181624. Epub 2019 Jan 25.
7
Hemagglutinin Stalk-Reactive Antibodies Interfere with Influenza Virus Neuraminidase Activity by Steric Hindrance.血凝素茎部反应性抗体通过空间位阻干扰流感病毒神经氨酸酶活性。
J Virol. 2019 Feb 5;93(4). doi: 10.1128/JVI.01526-18. Print 2019 Feb 15.
8
Universal protection against influenza infection by a multidomain antibody to influenza hemagglutinin.通过针对流感血凝素的多结构域抗体实现对流感感染的普遍保护。
Science. 2018 Nov 2;362(6414):598-602. doi: 10.1126/science.aaq0620.
9
Mutations in Influenza A Virus Neuraminidase and Hemagglutinin Confer Resistance against a Broadly Neutralizing Hemagglutinin Stem Antibody.甲型流感病毒神经氨酸酶和血凝素的突变赋予了对广泛中和血凝素茎抗体的抗性。
J Virol. 2019 Jan 4;93(2). doi: 10.1128/JVI.01639-18. Print 2019 Jan 15.
10
Universal Influenza Vaccines: Progress in Achieving Broad Cross-Protection In Vivo.通用流感疫苗:在体内实现广泛交叉保护的进展。
Am J Epidemiol. 2018 Dec 1;187(12):2603-2614. doi: 10.1093/aje/kwy145.